ENVB Enveric Biosciences, Inc.

Jay Pharma Inc. develops evidence-based cannabinoid products and combination therapies cure effects of cancer treatment. The company was incorporated in 2017 and is based in Toronto, Canada.

As of 12/03/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  06/19/2015
Outstanding shares:  31,383,632
Average volume:  1,055,755
Market cap:   $39,543,376
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    29405E109
ISIN:        US29405E1091
Valuation   (See tab for details)
PE ratio:   -4.73
PB ratio:   0.65
PS ratio:   -0.75
Return on equity:   -15.73%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy